Your browser doesn't support javascript.
loading
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.
Dal, Mehmet Sinan; Ulu, Bahar Uncu; Uzay, Ant; Akay, Olga Meltem; Besisik, Sevgi; Yenerel, Mustafa Nuri; Çelik, Serhat; Kaynar, Leylagül; Yücel, Orhan Kemal; Deveci, Burak; Sönmez, Mehmet; Mehtap, Özgür; Beköz, Hüseyin Saffet; Sunu, Cenk; Salim, Ozan; Ulas, Turgay; Karti, Sami; Altuntas, Fevzi; Ferhanoglu, Burhan; Tuglular, Tülin Firat.
  • Dal MS; Division of Hematology and Bone Marrow Transplantation Unit, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, 06200, Yenimahalle, Ankara, Turkey. dr.sinandal@gmail.com.
  • Ulu BU; Division of Hematology and Bone Marrow Transplantation Unit, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, 06200, Yenimahalle, Ankara, Turkey.
  • Uzay A; Hematology and Bone Marrow Transplant Unit, Atakent Hospital, Acibadem University, Istanbul, Turkey.
  • Akay OM; Division of Hematology, Department of Internal Medicine, Koç University Medical School, Istanbul, Turkey.
  • Besisik S; Division of Hematology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Yenerel MN; Division of Hematology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Çelik S; Division of Hematology, Department of Internal Medicine, Erciyes University, Kayseri, Turkey.
  • Kaynar L; Division of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Yücel OK; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
  • Deveci B; Hematology and Stem Cell Transplantation Unit, Medstar Antalya Hospital, Antalya, Turkey.
  • Sönmez M; Division of Hematology, Department of Internal Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Mehtap Ö; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Beköz HS; Division of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Sunu C; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
  • Salim O; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
  • Ulas T; Division of Hematology, School of Medicine, Department of Internal Medicine, Near East University, Nicosia, Cyprus.
  • Karti S; Hematology and Bone Marrow Transplant Unit, Atakent Hospital, Acibadem University, Istanbul, Turkey.
  • Altuntas F; Division of Hematology and Bone Marrow Transplantation Unit, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, 06200, Yenimahalle, Ankara, Turkey.
  • Ferhanoglu B; Division of Hematology, Department of Internal Medicine, School of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Tuglular TF; Division of Hematology, Department of Internal Medicine, Koc University School of Medicine and V.K.V. American Hospital, Istanbul, Turkey.
Ann Hematol ; 102(1): 133-140, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36401621
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma de Células B Grandes Difuso / Inmunoconjugados Límite: Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma de Células B Grandes Difuso / Inmunoconjugados Límite: Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article